RxDoctor Payments Data

Lilah Crews-Pless

Nurse Practitioner · Batavia, NYNPI 1649850579

Payments from drug & device makers

$2,063in general payments, 2019–2025

Across 111 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$395
  • Novo Nordisk$304
  • Pfizer$203
  • GSK$202
  • AstraZeneca$183
  • Amneal Pharmaceuticals LLC$160
  • plus $616 from 15 others

What the payments were for

  • Food & beverage$2,03198%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,063 in reported general payments places this provider in the 90th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide24$32,443
Repatha SureclickEvolocumab44$25,947
OzempicSemaglutide21$21,539
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$14,748
KerendiaFinerenone19$12,712
EliquisApixaban18$10,637
JardianceEmpagliflozin15$9,612
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$8,343
Pregabalin30$5,906
Pitavastatin Calcium13$3,085
Sucralfate11$3,064
Humalog Kwikpen U-100Insulin Lispro14$2,084
Omeprazole62$886
Rosuvastatin Calcium42$827
Methenamine Hippurate13$767

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$83$32,44324 claims
Novo NordiskOzempic$304$21,53921 claims
GSKTrelegy Ellipta$202$14,74824 claims
BayerKerendia$155$12,71219 claims
PfizerEliquis$203$10,63718 claims
Boehringer IngelheimJardiance$46$9,61215 claims
AstraZenecaBreztri Aerosphere$183$8,34312 claims
AbbVieSynthroid$395$67514 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$160$46234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,112 nurse practitioner providers in New York.

Other nurse practitioner in Batavia

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →